- Home
- SUNS vs SGMO Comparison
SUNS vs SGMO Comparison
Compare SUNS & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUNS
- SGMO
- Stock Information
- Founded
- SUNS 2023
- SGMO 1995
- Country
- SUNS United States
- SGMO United States
- Employees
- SUNS N/A
- SGMO N/A
- Industry
- SUNS Real Estate Investment Trusts
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SUNS Real Estate
- SGMO Health Care
- Exchange
- SUNS Nasdaq
- SGMO Nasdaq
- Market Cap
- SUNS 130.5M
- SGMO 122.8M
- IPO Year
- SUNS N/A
- SGMO 2000
- Fundamental
- Price
- SUNS $9.64
- SGMO $0.58
- Analyst Decision
- SUNS Strong Buy
- SGMO Strong Buy
- Analyst Count
- SUNS 3
- SGMO 7
- Target Price
- SUNS $13.58
- SGMO $5.29
- AVG Volume (30 Days)
- SUNS 57.4K
- SGMO 4.6M
- Earning Date
- SUNS 11-13-2025
- SGMO 11-14-2025
- Dividend Yield
- SUNS 12.20%
- SGMO N/A
- EPS Growth
- SUNS N/A
- SGMO N/A
- EPS
- SUNS 1.04
- SGMO N/A
- Revenue
- SUNS $16,359,932.00
- SGMO $81,706,000.00
- Revenue This Year
- SUNS $183.25
- SGMO $28.47
- Revenue Next Year
- SUNS $62.46
- SGMO N/A
- P/E Ratio
- SUNS $9.23
- SGMO N/A
- Revenue Growth
- SUNS 1342.10
- SGMO 565.52
- 52 Week Low
- SUNS $7.80
- SGMO $0.41
- 52 Week High
- SUNS $15.74
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- SUNS 41.11
- SGMO 39.09
- Support Level
- SUNS $9.56
- SGMO $0.56
- Resistance Level
- SUNS $10.12
- SGMO $0.69
- Average True Range (ATR)
- SUNS 0.36
- SGMO 0.05
- MACD
- SUNS 0.03
- SGMO -0.02
- Stochastic Oscillator
- SUNS 40.00
- SGMO 7.77
About SUNS Sunrise Realty Trust Inc. Common Stock
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.